- $11.50bn
- $26.03bn
- $20.67bn
- 85
- 86
- 80
- 97
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 9.77 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -2.94% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.76 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 10.3 | ||
| Price to Sales | 0.56 | ||
| EV to EBITDA | 4 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 24.15% | ||
| Return on Equity | 110.75% | ||
| Operating Margin | 28.78% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 17,640 | 19,485 | 19,174 | 20,548 | 20,665 | 20,877.21 | 21,950.41 | 2.26% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +301.13 | +158.95 | -4.09 | +77.01 | +32.9 | -7.51 | +8.65 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Tenet Healthcare Corporation is a diversified healthcare services company. The Company's segments include Hospital Operations and Services (Hospital Operations) and Ambulatory Care. The Hospital Operations segment is comprised of its acute care and specialty hospitals, a network of employed physicians and ancillary outpatient facilities. The Company's subsidiaries operate approximately 49 hospitals serving primarily urban and suburban communities in eight states. The Hospital Operations segment also includes around 135 outpatient facilities, including urgent care centers, imaging centers, off-campus hospital emergency departments and micro hospitals. It also provides revenue cycle management and value based care services. The Ambulatory Care segment, through its USPI Holding Company, Inc. subsidiary, holds ownership interests in approximately 518 ambulatory surgery centers, and 25 surgical hospitals in 37 states. The Company operates a Global Business Center in the Philippines.
Directors
- Ronald Rittenmeyer CHM (73)
- Saumya Sutaria CEO (48)
- Daniel Cancelmi CFO (58)
- Thomas Arnst EVP
- Paola Arbour EVP (57)
- Marie Quintana EVP (64)
- Howard Hacker EVP (49)
- J. Robert Kerrey LED (77)
- James Bierman IND (68)
- Richard Fisher IND (72)
- Meghan FitzGerald IND (50)
- Cecil Haney IND (65)
- Christopher Lynch IND (63)
- Richard Mark IND (65)
- Tammy Romo IND (58)
- Nadja West IND (60)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 7th, 1975
- Public Since
- May 22nd, 1981
- No. of Shareholders
- 3,053
- No. of Employees
- 74,480
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 94,372,262
- Address
- 14201 Dallas Parkway, DALLAS, 75254
- Web
- https://www.tenethealth.com/
- Phone
- +1 4698932200
- Auditors
- Deloitte & Touche LLP
Upcoming Events for THC
Q1 2025 Tenet Healthcare Corp Earnings Call
Tenet Healthcare Corp Annual Shareholders Meeting
Tenet Healthcare Corp Annual Shareholders Meeting
Q2 2025 Tenet Healthcare Corp Earnings Release
Similar to THC
Agilon Health
New York Stock Exchange
AMERICAN WELL
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Ardent Health Partners
New York Stock Exchange
Auna SA
New York Stock Exchange
FAQ
What is the Tenet Healthcare share price?
As of Today at 23:37 UTC, shares in Tenet Healthcare are trading at $121.81. This share price information is delayed by 15 minutes.
How has the Tenet Healthcare share price performed this year?
Shares in Tenet Healthcare last closed at $121.81 and the price had moved by +26.89% over the past 365 days. In terms of relative price strength the Tenet Healthcare share price has outperformed the S&P500 Index by +19.31% over the past year.
What are the analyst and broker recommendations for Tenet Healthcare?
The overall consensus recommendation for Tenet Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Tenet Healthcare dividend yield?
Tenet Healthcare does not currently pay a dividend.
Does Tenet Healthcare pay a dividend?
Tenet Healthcare does not currently pay a dividend.
When does Tenet Healthcare next pay dividends?
Tenet Healthcare does not currently pay a dividend.
How do I buy Tenet Healthcare shares?
To buy shares in Tenet Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Tenet Healthcare?
As of the previous close price of $121.81, shares in Tenet Healthcare had a market capitalisation of $11.50bn.
Where are Tenet Healthcare shares listed?
Here are the trading details for Tenet Healthcare:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: THC
What kind of share is Tenet Healthcare?
Based on an overall assessment of its quality, value and momentum Tenet Healthcare is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Tenet Healthcare share price forecast for 2025?
The analyst consensus target price for shares in Tenet Healthcare is $171.15. That is 40.51% above the last closing price of $121.81.
Analysts covering Tenet Healthcare currently have a consensus Earnings Per Share (EPS) forecast of $12.16 for the next financial year.
Find out moreWhat is the trend in the Tenet Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tenet Healthcare. Over the past six months, its share price has underperformed the S&P500 Index by -17.63%.
As of the last closing price of $121.81, shares in Tenet Healthcare were trading -14.81% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Tenet Healthcare PE Ratio?
The Tenet Healthcare PE ratio based on its reported earnings over the past 12 months is 9.77. The shares last closed at $121.81.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Tenet Healthcare?
Tenet Healthcare's management team is headed by:
- Ronald Rittenmeyer - CHM
- Saumya Sutaria - CEO
- Daniel Cancelmi - CFO
- Thomas Arnst - EVP
- Paola Arbour - EVP
- Marie Quintana - EVP
- Howard Hacker - EVP
- J. Robert Kerrey - LED
- James Bierman - IND
- Richard Fisher - IND
- Meghan FitzGerald - IND
- Cecil Haney - IND
- Christopher Lynch - IND
- Richard Mark - IND
- Tammy Romo - IND
- Nadja West - IND